Olmesartan Sandoz (Olmesartan Medoxomil)

Olmesartan medoxil, the active ingredient in Olmesartan Sandoz, is an angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan medoxil is an angiotensin II receptor antagonist used in the treatment of cardiovascular conditions that involve the renin‑angiotensin system.

- Hypertension: helps lower systolic and diastolic blood pressure. - Heart failure: used as part of combination therapy to improve cardiac output. - Diabetic nephropathy: slows progression of kidney damage associated with diabetes.

Adverse reactions to olmesartan may vary in frequency and severity.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhoea - Cough

Serious or Rare Side Effects: - Angio‑angulation: swelling of the lips, tongue or throat. - Severe hypotension: marked drop in blood pressure causing fainting. - Acute kidney injury. - Hyperkalemia: elevated potassium levels. - Liver enzyme elevation. - Bullous skin reactions.

Olmesartan should be used ​  

-       t   t  ...   t \\